Cost calculation model of introducing Upadacitinib and Risankizumab for adult ulcerative colitis and Crohn's disease in the Kingdom of Saudi Arabia
在沙特阿拉伯王国引入乌帕替尼和利沙珠单抗治疗成人溃疡性结肠炎和克罗恩病的成本计算模型
期刊:Saudi Journal of Gastroenterology
影响因子:2
doi:10.4103/sjg.sjg_245_25
Mosli, Mahmoud H; Almutairdi, Abdulelah A; Alshahrani, Abdullah M; Alkhurmi, Abdulrahman M; Fasseeh, Ahmad N; Anwar, Ali M; Alharbi, Bandar M; Altawil, Esraa S; Alshareef, Haneen J; Alqasim, Hussain A; Alharbi, Ibtisam H; El-Fass, Kareem A; Alanizy, Layla N; Almehizia, Rayd A; Hren, Rok; Iskandarani, Wael K; Alabdulkarim, Hana A